Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study
Authors
Anders Hviid (ORCID: https://orcid.org/0000-0002-7509-9127)
Henrik Svanström (ORCID: https://orcid.org/0000-0003-1015-7215)
Björn Pasternak (ORCID: https://orcid.org/0000-0002-2097-8466)
George Frederick Mkoma (ORCID: https://orcid.org/0000-0001-8073-3586)
Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study
Anders Hviid, Henrik Svanström, Björn Pasternak, George Frederick Mkoma
Citations
1 citations
Journal
The Lancet Regional Health - Europe
Topics
Heart Failure Treatment and Management
Field-Weighted Citation Impact (FWCI)
1.39
article
Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study
Anders Hviid, Henrik Svanström, Björn Pasternak, George Frederick Mkoma
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Regional Health - EuropeVol. 60
Institutions
Statens Serum Institut (DK), University of Copenhagen (DK), Karolinska Institutet (SE)